ArticleJCO precision oncology2025

Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Siddhartha Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.